CancerDrs

Colorectal Cancer clinical trials in Nevada

9 actively recruiting colorectal cancer trials at 5 sites across Nevada.

Data from ClinicalTrials.gov · last refreshed

Phase 2, Phase 3 Recruiting Academic/Other

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Sponsor: NRG Oncology
NCT ID: NCT05174169
Sites in Nevada:
  • Carson Tahoe Regional Medical Center — Carson City, Nevada
  • Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
  • OptumCare Cancer Care at Charleston — Las Vegas, Nevada
  • Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
  • Comprehensive Cancer Centers of Nevada - Central Valley — Las Vegas, Nevada
Phase 3 Recruiting Industry

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to understand if the new study medicine, combined with chemotherapy …

Sponsor: Pfizer
NCT ID: NCT07222800
Sites in Nevada:
  • Renown Health Medical Oncology — Reno, Nevada
  • Renown Regional Medical Center — Reno, Nevada
Phase 3 Recruiting Industry

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxalipl…

Sponsor: Janssen Research & Development, LLC
NCT ID: NCT06662786
Sites in Nevada:
  • Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
Phase 2 Recruiting Academic/Other

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

This phase III trial compares the addition of total ablative therapy to the usual systemic therapy versus the usual systemic therapy alone in treating patients with advanced colorectal cancer that has spread to up to 4 body sites (limited …

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05673148
Sites in Nevada:
  • Renown Regional Medical Center — Reno, Nevada
Phase 2 Recruiting Industry

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extensio…

Sponsor: Dogwood Therapeutics Inc.
NCT ID: NCT06848348
Sites in Nevada:
  • Central Recruiting Site — Las Vegas, Nevada
Phase 1 Recruiting Industry

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect of biomarkers of zanzalintinib administered alon…

Sponsor: Exelixis
NCT ID: NCT05176483
Sites in Nevada:
  • Exelixis Clinical Site #55 — Las Vegas, Nevada
NA Recruiting Academic/Other

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to participants randomized to surveillance colonoscopy at 5 and 10 years.

Sponsor: NRG Oncology
NCT ID: NCT05080673
Sites in Nevada:
  • Carson Tahoe Regional Medical Center — Carson City, Nevada
  • Cancer and Blood Specialists-Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Horizon Ridge — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Southeast Henderson — Henderson, Nevada
Recruiting Academic/Other

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …

Sponsor: Wake Forest University Health Sciences
NCT ID: NCT06418204
Sites in Nevada:
  • OptumCare Cancer Care at Seven Hills — Henderson, Nevada
  • OptumCare Cancer Care at Charleston — Las Vegas, Nevada
Recruiting Academic/Other

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

This study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic cancer that cannot be removed by surgery (unresectable) or is …

Sponsor: University of Rochester
NCT ID: NCT06073431
Sites in Nevada:
  • Carson Tahoe Regional Medical Center — Carson City, Nevada
  • Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
  • OptumCare Cancer Care at Seven Hills — Henderson, Nevada
  • Comprehensive Cancer Centers of Nevada-Southeast Henderson — Henderson, Nevada
  • Urology Specialists of Nevada - Green Valley — Henderson, Nevada

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-09-07